is glp-1 the same as tirzepatide Weight Loss Blog – Maryland Trim Clinic Effects of tirzepatide, a dual

Our protocol involves weekly subcutaneous injections in the abdomen, thigh, or upper arm

For these individuals, even modest weight loss can improve health outcomes

The landmark STEP trials documented an average weight loss of 15% of starting body weight over 68 weeks at the highest dose, compared to 2-3% with placebo

Semaglutide, like other peptide-based medications, undergoes gradual degradation over time, particularly when exposed to suboptimal storage conditions

It also leans into expanding therapeutic uses and making sure treatment is more accessible, for more people

Here is what a physician-guided transition plan looks like: Stabilize at goal weight for at least 36 months before beginning a taper this confirms your habits are working, not just the medication Gradual dose reduction rather than abrupt cessation typically stepping down over 23 months to allow appetite to readjust slowly Protein targets remain non-negotiable maintaining 1.21.6g/kg/day is the single most evidence-supported dietary habit for weight maintenance Resistance exercise at least 23 times per week muscle mass is your metabolic insurance policy after stopping Regular physician check-ins monthly weight and metabolic monitoring during and after tapering catches any concerning regain early Clear re-engagement plan agree in advance with your physician on the weight threshold that would prompt restarting medication Frequently Asked Questions Can I take semaglutide indefinitely